The ‘Advances in Diabetes’ module, taking place at BSAVA Congress 2024 in Manchester Central, will offer delegates the chance to hear first-hand from the clinical researchers and specialists who have used these drugs, such as Dr Ellen Behrend, Prof Ian Ramsey, Prof Stijn Niessen, and Dr Anna Lena Kramer.
Stijn said: “Although not suited as a sole therapeutic for dogs, the current data suggests that a majority of diabetic cats could be treated with once daily oral formulations of these drugs.
“Some of the past barriers to successful long term diabetic treatment included the owner having to inject insulin twice daily and having to watch for hypoglycaemia.
"These lifelong impacts on the owner’s lifestyle are now being taken away.”
Delegates will also be able to learn about advances in the monitoring of canine diabetes, such as the use of Freestyle Libre monitors and haemoglobin A1c, as well as a review of recent developments and management practices for ‘complicated’ cases.
Stijn added: “Gone are the days that we saw diabetes mellitus as a disease; instead, it is the consequence of one or many diseases.
“As such we now ought to approach diabetic cases with a much more open mind and being willing to try and determine the exact aetiology of the diabetes mellitus, doing so can pay off and prevent a diabetic case from becoming a complicated case.”
Ellen added: “Although diabetic ketoacidosis is no more common with the use of SGLT2-inhibitors, it is more likely to be euglycemic with a blood glucose <13.9 mmol/L.
"The recognition of euglycemic ketoacidosis and the correct approach of treatment is crucial.”
Stjn concluded: “Each patient is an individual and therefore diagnosis, treatment and monitoring practices should be adapted to the individual pet-owner combination.
Vets must adjust their approaches significantly when using these drugs, the ‘Advances in Diabetes’ module will provide an in-depth look at these adjustments.”
Delegates will also be able to get their hands on the brand new fifth edition of the BSAVA Manual of Canine and Feline Endocrinology, which includes a chapter on feline diabetes mellitus that discusses various treatments including the use of SGLT2-inhibitors.
Jacquie Rand, author of the chapter said: “SGLT2-Inhibitors will be a game-changer for diabetic cats and their owners. However, it is important that cats are diagnosed earlier in the disease process while some insulin secretory capacity is present, for these to be used as the sole drug therapy.”
The BSAVA Manual of Canine and Feline Endocrinology will be available to purchase on the BSAVA Publications Stand in the Exhibition Hall. ‘Advances in Diabetes’ will take place on Thursday 21st March in the Exchange Hall.
Registration for BSAVA members starts at £115 +VAT for a one-day event pass.
https://www.bsavacongress.com.
Illustration: What a presentation about SGLT2-Inhibitors might look like (this has been photoshopped)
In 2022, Winchester published the results of a study led by Professor Andrew Knight, which claimed the headline: "Vegan diets may be the healthiest to feed pet dogs, say researchers"1,2.
For the study, 2,639 dog owners were invited to report their own opinion of seven indicators of their dog's health.
The researchers also looked at the prevalence of 22 specific health disorders, reported as being based on 'predictions by vet assessments', finding 49% prevalence in traditional meat diets, 43% for raw meat diets and 36% for vegan diets.
However, it was not clear in the report what "predictions by vet assessments" actually means. Whose predictions? The vets'? Or the owners'?
Closer examination of the original study reveals it was "owners' predictions of vet assessments".
Owner-reported opinion, otherwise known as anecdote, is of course notoriously unreliable, and if there is one thing more unreliable than owner-reported opinion, it would surely be owner-reported opinion of their vet's opinion.
Furthermore, the original study was of an observational design, and therefore could only suggest correlation, not causation.
Lastly, the original analysis only looked at the relationship between diet and owner observations/opinion, without considering the impact of other factors assessed by the study, such as the age of the dog and whether the owner was a vegan.
For the new study3, therefore, researchers at the University of Liverpool led by Professor Alex German re-analysed the data used for the original study, in particular correcting the data for confounding variables.
When analysed in this way, significant illness in dogs correlated most strongly with the age of the dog, whether it was on medication, and the frequency of visit to the vet.
Compared to these, the association between owner opinions of health and feeding vegan dog food was minimal.
Co-author of the second study, Richard Barrett-Jolley, Professor of Neuropharmacology, said: “We know how seriously owners take their pet’s health.
"By revisiting and further interrogating these data, we have been able to draw more nuanced insights. “Crucially, we cannot draw a firm conclusion as to what diet type is actually best for dogs; this was never possible given the nature of the original dataset and study design.
"However, we can conclude that variables other than dog diet are more strongly associated with owner opinions about the health of their dog.”
References
Dechra Veterinary Products has launched Ketodale, an anti-inflammatory injection for cattle, horses and swine.
Ketodale contains the non-steroidal anti-inflammatory drug ketoprofen 100mg/ml. It is indicated for use in cattle and swine for diseases associated with inflammation, pain or fever. In cattle these include respiratory diseases, mastitis, osteoarticular and muscular-skeletal disorders, such as lameness and arthritis, and to ease pain post parturition. Ketodale can be used to treat swine suffering from Mastitis Metritis Agalactia (MMA) Syndrome and respiratory tract infections.
In horses, Ketodale is indicated for diseases affecting the osteoarticular and muscular-skeletal system associated with pain and inflammation. These include naviculitis, arthritis and laminitis. It can also be used for post-surgical inflammation and symptomatic therapy of colic and fever.
Ketodale is available in 50ml and 100ml vials.
To coincide with the product's launch, Dechra is carrying out a direct marketing campaign. Practices can take advantage of a special launch offer where they can purchase four vials and get a fifth free. The offer is available for a limited period only.
To find out more about Ketodale, call Dechra on 01743 441 632 or visiting www.dechra.com
A new study of UK snail behaviour using LED and UV light tracking has found that the nocturnal creatures can explore the length of an average British garden in just one night, reaching a top speed of 1mph (metre per hour).
The 'Slime Watch' report was commissioned by Bayer Animal Health, makers of Advocate, as part of its 'Be Lungworm Aware' campaign and led by Dr Dave Hodgson, Associate Professor of Ecology at the University of Exeter, who studied the habits of 450 garden snails, recording their movements using LED lights and UV paint. This is the first time snails have been studied in this way.
The study found that snails will travel distances of up to 25 metres in a 24-hour period, and seek out areas of shelter, such as long grass, trees or objects, including dogs' toys, left in the garden overnight. The four researchers from Exeter University also discovered that snails move in convoys, piggy-backing on the slime of other snails to conserve energy. It is thought that a snail could use up to 30 per cent of its energy in slime production alone.
Dr Hodgson said: "Until now no one has fully understood the habits of these fascinating creatures that we encounter in our gardens every day. In this research we wanted to solve the mystery surrounding gastropod activity and provide a resource for gardeners and pet owners wanting to better safeguard the health of their plants and pets. By learning more about the behaviour of snails, we hope dog owners can better understand they ways in which dogs can encounter snails on a day-to-day basis and the lungworm risk they present, taking the appropriate precautions."
Elanco says Baycox Iron offers a time-saving flexible dosing treatment which complements the company’s existing piglet gut health portfolio.
Louise Radford, marketing manager at Elanco, said: "By treating piglets at two or three days old, it’s possible to allow enough exposure to the coccidiosis parasite to enable them to develop natural immunity, while preventing any damage to the gut caused by subclinical and clinical coccidiosis which leads to poor growth and low weaning weights.
"By combining treatments, it's possible to limit the number of times they are handled, which in turn reduces stress and enhances growth”.
Elanco also makes the Coliprotec vaccine against post weaning diarrhoea (PWD).
Louise added: “As farmers and vets prepare for the removal of zinc oxide as a treatment option next year, focusing on gut health throughout all stages of development has never been more crucial.
For more information, contact your Elanco pig team specialist or visit https://www.myelanco.co.uk/cpd/swine/hub.
Having experienced the profession both as a clinician and as a director, Clive says he wanted to develop and integrate his skills to support fellow professionals. So, during lockdown, he embarked on a Master’s in Executive Coaching from Ashridge Hult Business School.
Clive said: "Studying for the Master’s was intellectually and emotionally tough. The emphasis was on psychology and relationships, working to the highest standards of ethical coaching practice. It has not only developed my coaching skills but also afforded me the opportunity to scrutinise the drivers and motivations behind my career choices and integrate them into a wider appreciation of life and my ‘self’. I am incredibly proud of this achievement and conscious of the privilege afforded me."
Clive's service typically involves six ninety-minute sessions during which he'll help you develop skills, behaviours and ways of behaving that will make you a better leader, particularly if you come from a clinical background where you'd be used to using very different skillset.
Clive, who is also a European Mentoring and Coaching Council Senior Practitioner, added: "In my practice as a coach, I am grateful for the opportunity to support others, whatever their life experiences, as they negotiate the challenges of being themselves, in the workplace, serving their communities.”
For more information, visit: www.trelliscoaching.co.uk
The vaccine will be available to order directly from Merial on receipt of a Special Import Certificate (SIC) issued by the VMD to the named vet. The SIC is only required once but needs to accommodate all potential doses required, enabling Merial to supply to direct orders from the practice.
The product is available in 10 dose packs at a net price of £89.00 per pack.
For further information, contact Merial Customer Support Centre (UK) on 0870 6000 123 or your local equine territory manager.
The dentistry group is one of a number of special interest groups being launched on VetSurgeon.org in the coming months which ALL members are invited to come and join.
The new groups make it much easier to find and follow content that interests you. More than that, they bring together members with a shared interest in the subject, thereby facilitating the sharing of information, experience and knowledge. To that end, expert contributors to the new dentistry group include: Pete Southerden, Norman Johnston, Bob Partridge and Evelyn Barbour-Hill.
As elsewhere on VetSurgeon.org, reading content in the new groups or participating in discussions can count towards a VetSurgeon.org CPD certificate. Just press 'Claim CPD' at the top of the page, then collect the record and certificate from your profile.
As elsewhere on VetSurgeon.org, there's also the opportunity for you to express your appreciation of shared information you've found helpful, by pressing the 'Thank you' button above content. We'll be rewarding those members who are most thanked by members of the site for their help.
The new groups have been set up partly in response to the growth in Facebook groups for vets and the need for VetSurgeon.org to offer added value over Facebook if it is to compete for your attention.
By virtue of the number of its numbers, Facebook probably can't be beaten for general 'chit chat'. But for clinical discussions, it has some serious flaws.
Firstly, there's minimal curation of content and it's more or less impossible to filter irrelevant stuff. Because of that, and because Facebook displays post excepts, rather than headlines, you can end up having to scroll as far as Australia to find stuff relating to your area of interest.
By contrast, the listings of latest content by title on VetSurgeon makes it much easier to scan the content and find the stuff that interests you, particularly now content is grouped by clinical discipline.
Perhaps even more importantly, it's impossible to see the professional qualifications of the person who replied to you on Facebook, so you don't necessarily know if they have the faintest idea what they are talking about. VetSurgeon profiles are visible to all, and allow members to display their postgrad veterinary qualifications, amongst other things.
Lastly, the way discussions on Facebook are 'threaded' makes it very, very difficult to refer back and find who said something useful (you remember someone said something, but then, on a busy thread, you may have to expand 20 or 20 threads to find the thing you were after). That's not just a pain in the derrière, it means that any valuable information shared by specialists and experts is too easily lost.
The bottom line is that if you're looking for general chat, Fleecebook may be your best bet. But if you have questions about specific clinical disciplines, VetSurgeon.org is where you'll find better answers, quicker.
The toolkit includes a 15-minute CPD webinar: ‘How to best use ProZinc to successfully manage diabetes in cats and dogs’, hosted by Dr Jamie Adams BVSc PhD MRCVS, Senior Brand Technical Advisor at Boehringer Ingelheim.
Vets who watch the webinar can enter a competition for a coffee machine for their veterinary practice by answering three questions at the end.
The toolkit also has a diabetes management reference guide covering how to make a confident diagnosis and start treatment with ProZinc, how best to monitor and reassess the patient and how to adjust the dose for optimal control.
There are also glucose curve charts, pet owner guides, home care journals and a link to the ProZinc pet owner website, www.prozinc.co.uk, which contains information to help owners feel confident in managing their pet’s diabetes.
The webinar and toolkit are available from: www.boehringer-academy.co.uk.
Founded in 2005 by Jane Howorth MBE, the British Hen Welfare Trust rehomes commercial laying hens that would usually be sent to slaughter, typically at 18 months.
The charity has rehomed hens in schools, community areas, prisons and back gardens around the country, where they have plenty of life left both as egg layers and companions.
The millionth hen, named Henrietta by His Majesty, was rehomed at Highgrove Gardens in Gloucestershire, along with 30 others earlier this month.
Jane said: “We’re thrilled that one million hens have been adopted and extremely pleased that Henrietta and her 30 feathered friends are heading to Highgrove Gardens.
"Helping a lorry load of 4,000 was my original target and we’ve exceeded my expectations by some margin!
"To think that so many hens have had a happy retirement gives me a great deal of pleasure as I’m sure it has for all the kind-hearted British supporters who’ve taken these deserving little creatures into their homes and hearts.
"From the day I started this charity, it’s been a privilege to meet and work with people who want to help hens and to work alongside the egg industry to champion hen welfare and free range eggs.”
www.bhwt.org.uk/one-millionth-hen.
An amendment to the EU's draft budget for a €2 million pilot research project into homeopathy and phytotherapy for farm animals has been approved today by the European Parliament's Agriculture Committee.
BVA President Harvey Locke, said: "Millions of Euros have already been spent on trying to prove the scientific efficacy of homeopathic medicines. To date we have not seen any data to prove they can be effective in the treatment of bacterial infections.
"Whilst it is unlikely that €2 million will be able to determine whether or not there is a basis for claiming homeopathic products can work, we welcome European investment in veterinary research and hope that the results of the pilot will be useful."
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
Reference
Norbrook Laboratories Ltd has launched a second generation Eprinomectin Pour On solution with zero milk withhold and a 10 day meat withdrawal period. Eprizero, for beef and dairy cattle, is indicated for the treatment and prevention of a range of economically damaging gutworm and lungworm infections and external parasites in a pour on application. It offers zero milk withhold and an improved meat withdrawal period of 10 days. Andrew Hillan MVB MRCVS, Director of Veterinary Science, Norbrook Laboratories Ltd., said: "Norbrook has launched Eprizero to offer vets and farmers a more versatile alternative in the treatment of economically damaging worms and external parasites. The active ingredient in Eprizero, Eprinomectin, is both potent and fast-acting and is supported by independent studies which show increased milk yield, improved fertility and increased dry matter intake following treatment. With a zero milk and 10 day meat withdrawal and waterproof properties, Eprizero offers real versatility to vets and farmers in terms of when and where they treat. It is this versatility that we believe will make Eprizero the gold standard in anthelmintic treatment for prolonged infestations of gut worm and lung worm in both dairy and beef cattle." Eprizero is available in four sizes - 250ml, 1L, 2.5L and 5L - with a free 75ml gun supplied with the two larger pack sizes. It is administered using a 75ml dispensing gun to enable accurate application. Eprizero is registered for use in the UK and Ireland and is available to order from your local Norbrook Sales Representative.
The procedure is called radiocatheter ablation. It's used regularly in humans but there are only three or four centres in the world that perform the procedure routinely on veterinary patients and Pedro is the only veterinary cardiologist currently performing it in the UK.
DVS says the procedure can achieve a cure for previously incurable conditions, without the need for further medical treatment with drugs that have potential side effects. It involves inserting catheters into veins in the legs and neck and then guiding them into the heart. Electrical signals can be recorded to show where the abnormal heartbeats are generated ('mapping'). Once this is achieved, heat is used to destroy the tiny abnormal area of the heart muscle and make the arrhythmia disappear ('zapping'). Recovery is straightforward and the condition can be completely cured.
Jake, a three-year-old Labrador Retriever, is one of seven dogs that have been cured by Pedro and the team so far.
Jake suffered from life-threatening cardiac arrhythmia, causing his heart to beat at over 250 beats per minute for prolonged periods. Such an elevated heart rate cannot be sustained for long and may result in damage to the heart muscle. Jake had been diagnosed a number of months ago and initially responded to anti-arrhythmic drugs. However, the drugs stopped working and his heart was sustaining damage and showing early signs of weakness. The radiocatheter ablation cured his condition completely and he can now lead a normal healthy life.
Jake’s owner, Mrs Chapman from Staffordshire, said: "We would like to thank everyone at Davies Veterinary Specialists for looking after Jake during his three day stay in April 2016. Special thanks to Pedro Oliveira and his cardiac team for operating on Jake and correcting his heart condition. Jake is no longer taking any medication and has made a full recovery. We now have a much happier, more energetic Labrador, ready for walks and play at every opportunity. Jake seems to have a smile on his face everyday now and is enjoying life to the full."
Pedro said: "We have treated seven patients in the past year, all with success and without complications. Unfortunately a significant proportion of candidates for these procedures are in desperate situations with failing hearts and after all drugs have failed before they reach us. Hopefully, with greater awareness of the availability of this procedure, we can treat more patients before it gets to be that bad."
Clive Elwood, Managing Director of Davies Veterinary Specialists said: "This is a great example of how our team of specialists can deliver ground-breaking and innovative care, which makes a real difference for both patients and their loving owners."
Pedro is happy to discuss the suitability of cases with vets managing dogs with arrhythmias. Contact him at cardiology@vetspecialists.co.uk or find out more at www.vetspecialists.co.uk
CVS has announced its acquisition of the Dovecote Veterinary Hospital, a general and referral practice based in Castle Donington near Derby.
The Dovecote offers a range of referral services including digital X-ray, MRI and CT scanning capability. Its directors, Andrew Robinson, a European RCVS Recognised Specialist in Small Animal Surgery, and Alison Robinson have been appointed joint Clinical Directors.
Dovecote joins ChesterGates Veterinary Specialists in Chester, Norfolk-based Grove Referrals and St David's Veterinary Group in Devon in CVS' referral practice portfolio. The Group also has a new veterinary hospital - Lumbry Park Veterinary Specialists - under construction at Alton, Hampshire; opening in October 2015.
In addition to the Dovecote, CVS has announced the acquisition of further first opinion practices based in Yorkshire and Wales. They are:
Simon Innes, Chief Executive of CVS, said: "These latest acquisitions show continued progress towards our goal of building a strong presence throughout all sectors of veterinary practice. It is a particularly exciting time for our referral team and we are delighted to welcome the team from Dovecote, as well as the other new practices which have joined us recently."
It's just over a year since microchipping became compulsory for dogs and according to Defra, 95% of dogs are now chipped.
However, the PDSA PAW Report 2016 showed that only 20% of Britain's 11m cats live an indoor-only life, meaning that there are 9 million 'free-range' cats at risk of getting lost if they stray too far from home.
The PDSA report also found 91% of veterinary professionals in the UK believe microchipping should be compulsory for cats.
Bayer says that advice to dog owners this year should focus on the importance of keeping their chip registration details up to date, after a BVA survey found 44% of veterinary surgeons still cannot reunite missing or stray dogs with their owners due to incorrect chip information being stored on the databases.1
Hannah Watts, Product Manager at Bayer said: "Until microchipping becomes compulsory in cats, vets will need to play a crucial role in helping increase the number of UK cats that are microchipped. National Microchipping month provides a great opportunity for vets to raise the subject with owners and to take advantage of the increased awareness and interest in the subject throughout June. With so many dogs now microchipped, ensuring owners are aware of the need to update their details on the microchipping database is an equally important educational message for vets to convey."
Bayer says that during National Microchipping Month, it will be actively driving pet owners into veterinary practices across the country to discuss the benefits of microchipping with their veterinary surgeon. It will also be trying to ensure pet owners understand the importance of keeping the details stored on their pet’s microchip database up to date.
To help drive home the message, Bayer has also developed a range of new marketing and support materials for practices to display throughout June.
To order National Microchipping Month support materials, visit www.vetcentre.bayer.co.uk or speak to your Bayer Territory Manager.
There are 10 candidates standing in this year’s elections, including four existing Council members eligible for re-election and six candidates not currently on Council. They are:
Mr David Catlow MRCVS
Mr John C Davies MRCVS
Dr Mandisa Greene MRCVS
Miss Karlien Heyrman MRCVS
Professor John Innes FRCVS
Dr Thomas Lonsdale MRCVS
Dr Susan Paterson FRCVS
Mr Matthew Plumtree MRCVS
Mr Iain Richards MRCVS
Colonel Neil Smith FRCVS
Ballot papers and candidates' details have been posted to all veterinary surgeons eligible to vote and an email containing a link to a secure voting site unique to each member of the electorate has also been sent by Electoral Reform Services which runs the election on behalf of the College.
All votes must be cast, either online or by post, by 5pm on Friday 27 April 2018.
This year the College invited all election candidates to produce a video in which they answered up to two questions submitted directly to the RCVS from members of the electorate. All videos have been published on the RCVS website (www.rcvs.org.uk/vetvote18) and YouTube channel (www.youtube.com/rcvsvideos).
Key question themes this year included recruitment and retention, the College’s concerns investigation process and veterinary education. The list of accepted questions has also been published on the RCVS website.
The biographies and statements for each candidate in the RCVS Council election can be found at www.rcvs.org.uk/vetvote18.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "Last year we had a record number and proportion of the electorate vote in an RCVS Council election and we would once again stress the importance of voting to ensure that you have a say in the future direction of travel for the College and its policies."
Those who are eligible to vote but have not received either an email or ballot paper should contact Luke Bishop, RCVS Senior Communications Officer, on l.bishop@rcvs.org.uk.
The partnership includes a minimum donation of £10,000 which the company hopes to bolster with additional volunteering and fundraising support.
Gerard Ensink, Head of Animal Health UK and Ireland at Boehringer Ingelheim said: “We are truly delighted to be supporting StreetVet.
“There is already so much passion for the charity within our company.
"Even before we announced this charity partnership, several of our colleagues have been volunteers with StreetVet in a personal capacity.
"We look forward to supporting StreetVet and believe that together we can make a real difference to individuals and their pets who are experiencing homelessness.”
https://www.streetvet.co.uk
The two companies have agreed to jointly discover and develop species-specific therapeutic monoclonal antibodies for companion animals, a class of drug which they say is neglected in veterinary medicine but offers a variety of future therapeutic options for diseases that cannot be adequately treated today.
adivo will select species-specific antibodies using its proprietary fully canine phage display library. Bayer Animal Health will provide targets involved in severe animal diseases.
Dr. Douglas Hutchens, Bayer Animal Health’s Head of Drug Discovery, External Innovation & Chief Veterinary Officer, said: "Today’s agreement is another example of how we realize our innovation strategy
"By combining the know-how from creative start-up companies like adivo with opportunities derived from Bayer’s research, we broaden our space of therapeutic medicine options and complement our portfolio.
"We are constantly looking for innovative technologies that enable us to generate novel treatment options for the companion animal sector. Now, we will focus on evolving the options presented by adivo from research and development to market maturity."
Dr. Kathrin Ladetzki-Baehs, Managing Director of adivo said: "At adivo, we truly believe that pets have a positive impact on our society. By developing novel medicines for companion animals, we want to make a difference for veterinarians and pet-parents. Today, we are more than pleased and excited to have gained such a committed and experienced collaboration partner, to jointly develop new treatment options."
The divestment is expected to be concluded in mid-2020, and Bayer intends to exit its stake in Elanco over time.
Bayer says that combining Elanco and Bayer Animal Health will create the number two animal heath company, with top three positions across a broad range of species and geographies. It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.
Jeffrey N. Simmons, president and chief executive officer of Elanco, said: "Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers. We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company, providing a sustained flow of innovation for farmers, veterinarians and pet owners."
Zoetis says the new product is designed to stimulate both cell-mediated and antibody-based immunity, providing a broad immune response that mimics a natural infection.
The company says CircoMax Myco has demonstrated robust performance in field conditions, delivering improvements in average daily gain (ADG) and close-out weights versus negative controls, helping producers get more kilograms of pork to market.
CircoMax Myco comes in a ready to use single-dose combination with a duration of immunity (DOI) of 23 weeks against both PCV2 and M. hyopneumoniae.
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: “The swine industry needs to adapt to evolving challenges and our research has consistently demonstrated that with its unique technology CircoMax Myco offers robust protection against PCV2 and M. hyopneumoniae.
"It also shows that this new product offers the best chance at protection against continuously evolving PCV2 genotypes – providing a broader umbrella for pig health and productivity.
"Analysis of new European PCV2 strains isolated in multiple countries confirm that CircoMax Myco offers broader coverage than competitor vaccines based on PCV2a only.”
Janssen Animal Health has produced a new DVD called 'Fluke: That's a Fact', which is available free from the company.
The 18 minute film features TV presenter Michaela Strachan discussing the big issues surrounding fluke in sheep, such as the effects on productivity and fertility and the need to adapt treatment regimes to reflect the current challenge in the environment, weather patterns and the possibility of resistance to commonly used flukicides. There is also a section on Haemonchus, the Barber's Pole worm, as the parasite has been reported in a number of farms in the last few years.
According to the company, fluke is becoming increasingly common and is moving into new areas of the UK. There is increasing evidence that a single autumn / winter dose of flukicide may not always be enough to control the disease on some farms and more frequent dosing programmes are now often proposed that look more long term to reduce the level of the disease on farms, especially on those farms with high infection pressure. The film clearly explains these different approaches and the benefits of treating at various times of the year.
Janssen's Livestock Marketing Manager Nigel Underwood hopes the film will be a great educational tool that will help both farmers and SQPs better understand the disease: "With ten easy to watch sections, people will be able to listen to the whole story or just dip into those areas where they feel they need to know more. With her long standing interest in the countryside and wildlife, Michaela Strachan was the perfect choice to present what can be a rather complex story and I'm sure everyone will enjoy her clear explanation of the facts."
To request a DVD or for further information, please contact Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG. Tel 01494 567555 Fax 01494 567556 Email: ahealth@its.jnj.com www.janssenanimalhealth.com/uk
Eastcott says all staff working in the ECC unit have received specific intensive care training and will be supported by discipline-specific specialists at all times.
The service will be run by three ECC/medicine vets during the day and three ECC vets at night, supported by four day nurses and two night nurses.
David said: “We’ve created a purpose-built intensive care unit with all the latest ICU equipment, including our own laboratory; critical care cribs; temperature, humidity and oxygen-controlled intensive care kennels and an ICU ventilator.
“This means we have the facilities to care for the most severely injured and critical cases.
“We also have a high-quality team of enthusiastic, dedicated ECC vets and nurses to lead the service. Everyone has a background of ECC work and a true passion for it.”
Harriet said: “By having all the specialist disciplines available at the practice, we can offer a more holistic service to emergency patients. For example, if a dog is involved in a road traffic accident, the ICU can stabilise it and give emergency care and pain relief.
“Dentistry can then repair jaw and mouth injuries; orthopaedics can repair any other broken bones and soft tissue can assess and repair any damaged organs. This is all supported by our dedicated anaesthesia service and advanced imaging capabilities.
“The ICU also provides a calm environment for critically ill and injured patients to recover following surgery or other planned treatments from other disciplines.”
For more information, visit www.eastcottreferrals.co.uk.
The Action Plan presents what the College is doing to tackle the issue and explains how collaboration, culture change, career development and leadership, among other things, could help with workforce shortages by improving retention of current members of the professions, encouraging more people to join, and making it easier for those who have left the professions to return.
The report lists seven main areas to be addressed:
The full list of actions, with context about what has fed into ambitions, can be found in the Action Plan which is downloadable at www.rcvs.org.uk/publications.
Dr Sue Paterson FRCVS, Junior Vice-President and Chair of the RCVS Advancement of the Professions Committee, said: “This is a very complex, broad and multi-faceted area of concern so the Action Plan has been a long time in the making to ensure that we adequately capture what needs doing and how, in order to enable us to work collaboratively with all veterinary organisations going forward.
"This is not a finished list, but gives all within the veterinary sector the ability to look at the key areas of work that need to be done and prioritise the ones that most suit their organisational needs."
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
The company will continue to offer attended modular training options as well as small group practical teaching sessions at its wet labs in Swindon and Sheffield. It says these events will complement its online programmes and will provide stand-alone training for vets wishing to learn new surgical and diagnostic skills.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes, together with exams that can be taken remotely.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
“We start this new chapter in a world changed irrevocably by COVID-19. It is a world in which veterinary professionals are demanding more flexible ways of learning and showing a hunger to achieve additional qualifications. With this in mind, we will be working to offer a combination of high quality practical, remote and blended learning that will make the achievement of a postgraduate qualification a realistic ambition for every vet."